The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...

(NASDAQ:VRTX) has recently achieved a significant milestone with the FDA's approval of JOURNAVX(suzetrigine), a novel ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

India’s weak drug regulation is spreading a problem from Africa to America. Reputational damage can be big India’s drug regulators have been caught napping once again. Various pills made by ...

The case emerged following an investigative report by BBC, which uncovered the sale of Aveo-branded combination medicines in ...

Aveo Pharmaceuticals is accused of illegally exporting banned combination of tapentadol and carisoprodol to Nigeria, Ghana ...

West Virginia has the highest opioid overdose mortality rate in the country, and leaders are bringing new legislation into ...

In looking at the profound impact on satiety that GLP-1s have, Penn State College of Medicine Drs. Patrician Grigson and ...

FDA officials have identified nine more companies allowed to manufacture and export a banned, lethal drug combination linked ...

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.

Advancements have been made in the pain management field that have successfully found FDA approved alternatives to ...